- Hyzon Motors ( HYZN ) -36% after disclosing operational inefficiencies, financial issues .
- Helius Medical Technologies ( HSDT ) -30% .
- Quoin Pharmaceuticals ( QNRX ) -23% .
- Chembio Diagnostics ( CEMI ) -18% on Q2 earnings release .
- Doximity ( DOCS ) -16% on FQ1 earnings release .
- Exicure ( XCUR ) -16% .
- Virgin Galactic Holdings ( SPCE ) -14% on Q2 earnings release .
- Warner Bros. Discovery ( WBD ) -13% on Q2 earnings release ; as Barclays frets over 'bigger than anticipated' EBITDA cut .
- Minerva Neurosciences ( NERV ) -13% .
- InVivo Therapeutics ( NVIV ) -11% .
- Cognition Therapeutics ( CGTX ) -11% on presenting new proteomic data on effect of CT1812 treatment .
- Society Pass ( SOPA ) -10% on Q2 earnings release .
- NanoViricides ( NNVC ) -10% .
- BiondVax Pharmaceuticals ( BVXV ) -10% .
- Greenpro Capital ( GRNQ ) -10% .
- Histogen ( HSTO ) -10% .
- Aclarion ( ACON ) -10% .
- Astra Space ( ASTR ) -9% on Q2 earnings release .
- Iveda Solutions ( IVDA ) -9% .
- AMC Entertainment Holdings ( AMC ) -9% on narrower-than-expected Q2 loss .
- Twilio ( TWLO ) -9% on Q2 earnings release ; as Stifel downgrades after company issues weak Q3 guidance .
- GrowGeneration ( GRWG ) -8% on Q2 earnings release .
- 36Kr Holdings ( KRKR ) -8% .
- Canopy Growth ( CGC ) -8% on FQ1 earnings release .
- Zillow Group ( Z ) -7% on Q2 earnings release .
For further details see:
Warner Bros. Discovery, Twilio, AMC Entertainment Holdings among premarket losers' pack